Daptacel - Corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated), clostridium tetani toxoid antigen (formaldehyde inactivated), bordetella pertussis toxoid antigen (glutaraldehyde inactivated), bordetella pertussis filamentous hemagglutinin antigen (formaldehyde inactivated), bordetella pertussis pertactin antigen, and bordetella pertussis fimbriae 2/3 antigen 5 ug / .5mL; 5 ug / .5mL; 3 ug / .5mL; 10 ug / .5mL; 5 [Lf] / .5mL; 15 [Lf] / .5mL Injection 0.5 mL

Reference details for licensed healthcare facility review and verification.

NDC 1149281-0286-10
Product NDC49281-0286
Generic Drug Namecorynebacterium diphtheriae toxoid antigen (formaldehyde inactivated), clostridium tetani toxoid antigen (formaldehyde inactivated), bordetella pertussis toxoid antigen (glutaraldehyde inactivated), bordetella pertussis filamentous hemagglutinin antigen (formaldehyde inactivated), bordetella pertussis pertactin antigen, and bordetella pertussis fimbriae 2/3 antigen
Brand NameDaptacel
ManufacturerSanofi Pasteur Inc.
Strength5 ug / .5mL; 5 ug / .5mL; 3 ug / .5mL; 10 ug / .5mL; 5 [Lf] / .5mL; 15 [Lf] / .5mL
Dosage FormInjection
Drug TypeIntramuscular
Package Quantity10 Vial
Package Description10 VIAL in 1 PACKAGE (49281-286-10) / .5 mL in 1 VIAL (49281-286-58)
Active IngredientsBordetella Pertussis Filamentous Hemagglutinin Antigen (Formaldehyde Inactivated); Bordetella Pertussis Fimbriae 2/3 Antigen; Bordetella Pertussis Pertactin Antigen; Bordetella Pertussis Toxoid Antigen (Glutaraldehyde Inactivated); Clostridium Tetani Toxoid Antigen (Formaldehyde Inactivated); Corynebacterium Diphtheriae Toxoid Antigen (Formaldehyde Inactivated)
Marketing CategoryBLA

Unless explicitly stated in writing, no direct affiliation, sponsorship, or endorsement by individual product manufacturers with Premium Rx National, LLC should be implied. All brand names, trade names, and trademarks are the property of their respective owners and are presented solely for accurate product identification and informational reference.

NDC snapshot

corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated), clostridium tetani toxoid antigen (formaldehyde inactivated), bordetella pertussis toxoid antigen (glutaraldehyde inactivated), bordetella pertussis filamentous hemagglutinin antigen (formaldehyde inactivated), bordetella pertussis pertactin antigen, and bordetella pertussis fimbriae 2/3 antigen 5 ug / .5mL; 5 ug / .5mL; 3 ug / .5mL; 10 ug / .5mL; 5 [Lf] / .5mL; 15 [Lf] / .5mL Injection is tracked under NDC 49281-0286-10 and rolls up into product family 49281-0286. Use this page to review package-level identifiers before comparing related family pages or starting a quote review.

  • Package configuration: 10 Vial.
  • Manufacturer: Sanofi Pasteur Inc..
  • Dosage form: Injection.
  • Family size: 3 indexed presentations.

Official references

Use official labeling and directory references to confirm presentation details while your team reviews the PRN catalog entry and related sourcing paths.

Alternate presentations in this family

These nearby package-level pages can help healthcare teams compare related packaging or presentation differences inside the same product-NDC family.

Drug Shortage Information

Shortage summary

Public sources include one strong historical shortage/supply update plus product identification sources for DAPTACEL NDC 49281-286-10.

This section is intended to help healthcare teams review public shortage history and related availability references for this product. Supply conditions can change quickly across manufacturers, distributors, and care settings, and these references may not reflect the latest market status. Premium Rx National does not guarantee completeness or suitability for clinical, operational, or purchasing decisions. Please confirm current availability with FDA, manufacturers, and other authoritative sources before relying on this information.

Daptacel - Corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated), clostridium tetani toxoid antigen (formaldehyde inactivated), bordetella pertussis toxoid antigen (glutaraldehyde inactivated), bordetella pertussis filamentous hemagglutinin antigen (formaldehyde inactivated), bordetella pertussis pertactin antigen, and bordetella pertussis fimbriae 2/3 antigen 5 ug / .5mL; 5 ug / .5mL; 3 ug / .5mL; 10 ug / .5mL; 5 [Lf] / .5mL; 15 [Lf] / .5mL Injection 0.5 mL, NDC 49281-0286-10, is a Sanofi Pasteur Inc. 5 ug / .5mL; 5 ug / .5mL; 3 ug / .5mL; 10 ug / .5mL; 5 [Lf] / .5mL; 15 [Lf] / .5mL injection presentation packaged as 10 Vial. Historical public shortage information is available for this product reference.